Elpis Chochliourou

Prof. Elpis Chochliourou

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2026 in Stresses
Verified
Journal Article
Open access
PDF file
NGNefeli Maria Georgaki
Nefeli Maria Georgaki
DIDespoina Ioannou
Despoina Ioannou
KSKanellos Skourtsidis
Kanellos Skourtsidis
ECElpis Chochliourou
Elpis Chochliourou
Dimosthenis SarigiannisDimosthenis Sarigiannis
Dimosthenis Sarigiannis
Chromium (Cr) remains a significant environmental health concern, with exposure mainly through ingestion and inhalation. Its toxicological profile is driven by oxidation state: trivalent chromium [Cr(III)] shows low bioavailability, whereas hexavalent chromium [Cr(VI)] is highly bioavailable, crosses cell membranes, and generates reactive intermediates associated with oxidative and genotoxic effects. Several studies have highlighted the assessment of chromium exposure, particularly Cr(III) and Cr(VI), across different biological matrices as a key approach for accurate exposure characterization. This review synthesizes experimental and epidemiological evidence regarding urinary chromium (uCr) as a biomarker of exposure, alongside advances in analytical techniques and the emerging exposome framework. Although widely used due to non-invasive sampling and suitability for large studies, uCr primarily reflects recent exposure (<48 h), exhibits high intra- and inter-individual variability, and lacks routine Cr(VI)/Cr(III) speciation, limiting its value for low-level environmental exposure. Unlike urinary or whole blood chromium, chromium in red blood cells (RBCs) is specific to Cr(VI) exposure, since in vitro studies reveal selective, donor-independent accumulation of hexavalent chromium in RBCs. However, the current literature is primarily concerned with sampling strategies, pre-treatment procedures, and analytical validation, with comparatively little consideration given to chromium speciation and species interconversion in biological matrices, despite their essential significance for exposure assessment and toxicological interpretation.

26 February 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
JOHN DOTISJOHN DOTIS
JOHN DOTIS
ASAlexandra Christos Skarlatou
Alexandra Christos Skarlatou
MFMaria Dimitrios Fourikou
Maria Dimitrios Fourikou
APAthina Papadopoulou
Athina Papadopoulou
ECElpis Chochliourou
Elpis Chochliourou
Background/Objectives: Preterm birth interrupts nephrogenesis during a critical developmental window, resulting in reduced nephron endowment and lifelong renal vulnerability. Evidence indicates that individuals born preterm are at increased risk for hypertension, albuminuria, and chronic kidney disease (CKD) across the life course. This review synthesizes current evidence linking prematurity with adverse renal outcomes, explores key pathophysiological mechanisms, and discusses emerging biomarkers together with therapeutic strategies. Methods: This comprehensive review integrates evidence from clinical cohort studies, population-based registries, meta-analyses and experimental models. Factors such as neonatal acute kidney injury (AKI), nephrotoxic exposures and cardiometabolic interactions were integrated to provide a life-course perspective. Results: Preterm birth leads to reduced nephron endowment, compensatory glomerular hypertrophy, and hyperfiltration, which predispose to progressive nephron loss. Postnatal factors, including neonatal AKI, inflammation, nephrotoxic medications, and later cardiometabolic stress, act as cumulative “hits”, accelerating renal injury trajectories. Clinical studies demonstrate a higher prevalence of reduced estimated glomerular filtration rate, albuminuria, elevated blood pressure, and smaller kidney volumes from childhood into adulthood. Emerging biomarkers such as cystatin C, alongside imaging-based estimates of nephron endowment, may enhance early risk stratification. Conclusions: Preterm birth represents an independent, lifelong risk factor for CKD through combined developmental and postnatal mechanisms. Structured long-term surveillance and early preventive strategies are essential to preserve renal reserve in this population. Advances in biomarker-guided monitoring and targeted interventions may enable earlier identification of high-risk individuals and support precision approaches to nephroprotection after prematurity.

24 October 2025 in Children
Verified
Journal Article
Open access
PDF file
JOHN DOTISJOHN DOTIS
JOHN DOTIS
ASAlexandra Christos Skarlatou
Alexandra Christos Skarlatou
MFMaria Dimitrios Fourikou
Maria Dimitrios Fourikou
APAthina Papadopoulou
Athina Papadopoulou
ECElpis Chochliourou
Elpis Chochliourou
Background/Objectives: Furosemide is frequently used in preterm neonates for respiratory and fluid management but has been linked to nephrocalcinosis (NC), a renal complication with unclear long-term impact. Clarifying this association is crucial for safe diuretic use. Methods: A focused literature review included observational studies published between 1982 and 2025 reporting NC incidence by renal ultrasound in preterm infants receiving furosemide. Data on sample size, gestational age, birth weight, NC prevalence, and furosemide dosing/duration were extracted. Results were synthesized descriptively. Results: Twenty-two studies with 1489 infants were included. NC prevalence ranged 6–83%, higher in infants <32 weeks’ gestation or <1500 g. Across studies, incidence clustered at 17–41% between 4 weeks and term-equivalent age. Cumulative furosemide doses were generally three- to fourfold higher in NC groups (10–19 mg/kg cumulative vs. ≤5 mg/kg cumulative, p < 0.001). A dose-dependent risk was noted, with odds ratios increasing above a cumulative dose of 10 mg/kg. Some studies found no significant dose–response, indicating variability and confounding factors. NC was detected during NICU stay or around term-equivalent age; ~60% resolved after discontinuation, while persistent cases were associated with prolonged exposure and renal dysfunction. A recent multicenter, dose-escalation randomized trial showed that carefully dosed furosemide (≤2 mg/kg/day for 28 days) did not increase NC risk, though electrolyte disturbances were more frequent. Conclusions: Evidence supports a dose-related association between furosemide and NC in preterm infants. When administered cautiously within defined limits, risk may be mitigated. Careful dosing, monitoring, and further studies are essential for safe use.

2 April 2026 in Journal of Xenobiotics
Verified
Journal Article
Open access
PDF file
NGNefeli Maria Georgaki
Nefeli Maria Georgaki
DIDespoina Ioannou
Despoina Ioannou
ECElpis Chochliourou
Elpis Chochliourou
KSKanellos Skourtsidis
Kanellos Skourtsidis
Theodora PapamitsouTheodora Papamitsou
Theodora Papamitsou
Dimosthenis SarigiannisDimosthenis Sarigiannis
Dimosthenis Sarigiannis
Background: Brain-derived neurotrophic factor (BDNF) is central to synaptic plasticity and neurodevelopment. Toxic metal exposure is linked to oxidative stress and neuroinflammation, yet its effects on BDNF signaling remain unclear. Objectives: To systematically synthesize evidence from human and experimental studies on the association between environmental or occupational metal exposure and BDNF alterations, and to highlight research gaps with an emphasis on hexavalent chromium (Cr(VI)). Methods: PubMed, Scopus, and ScienceDirect were searched following PRISMA guidelines. Eligible studies included human observational research and animal models reporting quantitative associations between metal exposure (biomarkers/environmental measures) and BDNF outcomes (protein or gene expression). Data were extracted on exposure assessment, BDNF measurement, and neurobehavioral outcomes. Study quality was assessed using NOS (human studies) and SciRAP (experimental studies). Results: Nineteen studies were included. Across metals such as Pb, Hg, Cd, As, Mn, and mixtures, exposure was associated with altered BDNF levels in blood or brain tissue, often alongside oxidative stress markers, inflammatory changes, and cognitive or behavioral impairment in animal models. Most human studies reported decreased circulating BDNF with higher exposure, while experimental evidence suggested context-dependent regulation across exposure windows and brain regions. Conclusions: The available evidence supports a biologically plausible link between metal exposure and BDNF dysregulation. No eligible studies evaluated BDNF in relation to Cr(VI), indicating a major research gap. Future studies should integrate neurotrophic biomarkers with exposome-oriented designs to clarify chromium-related neurotoxicity and support Adverse Outcome Pathway (AOP)-informed frameworks.

Verified
Conference Paper
Open access
PDF file
NGNefeli Maria Georgaki
Nefeli Maria Georgaki
LPLambrini Papadopoulou
Lambrini Papadopoulou
DIDespoina Ioannou
Despoina Ioannou
CGCatherine Gabriel
Catherine Gabriel
ECElpis Chochliourou
Elpis Chochliourou
Dimosthenis SarigiannisDimosthenis Sarigiannis
Dimosthenis Sarigiannis
Red blood cells (RBCs) are sensitive biomarkers of human health, influenced by urbanization and agricultural exposures. Using scanning electron microscopy (SEM) within an exposome framework, we examined RBC morphology in residents of an industrialized area of Thessaloniki, Greece, and in a rural population primarily exposed to agricultural stressors. Blood samples and questionnaires covering demographics, lifestyle, and environmental factors were statistically analyzed. SEM revealed moderate morphological alterations without significant differences between groups. Observed features were associated with longer residence duration and suboptimal nutrition, suggesting subclinical cellular stress. Integrating these findings into exposome research may clarify cumulative industrial and agricultural impacts on RBC morphology.

31 July 2026 in Journal of Cluster Science
Verified
Journal Article
Closed access
PDF file
ECElpis Chochliourou
Elpis Chochliourou
NGNefeli Maria Georgaki
Nefeli Maria Georgaki
DIDespoina Ioannou
Despoina Ioannou
ITIoannis Trevlias
Ioannis Trevlias
Dimitrios KavvadasDimitrios Kavvadas
Dimitrios Kavvadas
Theodora PapamitsouTheodora Papamitsou
Theodora Papamitsou